225 related articles for article (PubMed ID: 21306583)
1. Formoterol and salmeterol induce a similar degree of β2-adrenoceptor tolerance in human small airways but via different mechanisms.
Cooper PR; Kurten RC; Zhang J; Nicholls DJ; Dainty IA; Panettieri RA
Br J Pharmacol; 2011 Jun; 163(3):521-32. PubMed ID: 21306583
[TBL] [Abstract][Full Text] [Related]
2. Comparative trough effects of formoterol and salmeterol on lymphocyte beta2-adrenoceptor--regulation and bronchodilatation.
Aziz I; McFarlane LC; Lipworth BJ
Eur J Clin Pharmacol; 1999 Aug; 55(6):431-6. PubMed ID: 10492055
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological characterization of indacaterol, a novel once daily inhaled 2 adrenoceptor agonist, on small airways in human and rat precision-cut lung slices.
Sturton RG; Trifilieff A; Nicholson AG; Barnes PJ
J Pharmacol Exp Ther; 2008 Jan; 324(1):270-5. PubMed ID: 17916760
[TBL] [Abstract][Full Text] [Related]
4. Desensitisation of mast cell beta2-adrenoceptor-mediated responses by salmeterol and formoterol.
Scola AM; Chong LK; Suvarna SK; Chess-Williams R; Peachell PT
Br J Pharmacol; 2004 Jan; 141(1):163-71. PubMed ID: 14662724
[TBL] [Abstract][Full Text] [Related]
5. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists.
van der Woude HJ; Winter TH; Aalbers R
Thorax; 2001 Jul; 56(7):529-35. PubMed ID: 11413351
[TBL] [Abstract][Full Text] [Related]
6. Salmeterol, formoterol, and salbutamol in the isolated guinea pig trachea: differences in maximum relaxant effect and potency but not in functional antagonism.
Lindén A; Bergendal A; Ullman A; Skoogh BE; Löfdahl CG
Thorax; 1993 May; 48(5):547-53. PubMed ID: 8100652
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological basis for duration of effect: formoterol and salmeterol versus short-acting beta 2-adrenoceptor agonists.
Lindén A; Rabe KF; Löfdahl CG
Lung; 1996; 174(1):1-22. PubMed ID: 8746998
[TBL] [Abstract][Full Text] [Related]
8. Different effects of salmeterol, formoterol and salbutamol on cholinergic responses in the ferret trachea.
Bergendal A; Lindén A; Lötvall J; Skoogh BE; Löfdahl CG
Br J Pharmacol; 1995 Apr; 114(7):1478-82. PubMed ID: 7606351
[TBL] [Abstract][Full Text] [Related]
9. In vivo effect of albuterol on methacholine-contracted bronchi in conjunction with salmeterol and formoterol.
Aziz I; Lipworth BJ
J Allergy Clin Immunol; 1999 May; 103(5 Pt 1):816-22. PubMed ID: 10329815
[TBL] [Abstract][Full Text] [Related]
10. Formoterol on airway smooth muscle and human lung mast cells: a comparison with salbutamol and salmeterol.
Nials AT; Ball DI; Butchers PR; Coleman RA; Humbles AA; Johnson M; Vardey CJ
Eur J Pharmacol; 1994 Jan; 251(2-3):127-35. PubMed ID: 8149969
[TBL] [Abstract][Full Text] [Related]
11. Budesonide prevents cytokine-induced decrease of the relaxant responses to formoterol and terbutaline, but not to salmeterol, in mouse trachea.
Adner M; Larsson B; Säfholm J; Naya I; Miller-Larsson A
J Pharmacol Exp Ther; 2010 Apr; 333(1):273-80. PubMed ID: 20061444
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of inflammatory mediator release by beta(2)-adrenoceptor agonists in airway epithelial cells is reversed by glucocorticoid action.
Holden NS; Rider CF; Bell MJ; Velayudhan J; King EM; Kaur M; Salmon M; Giembycz MA; Newton R
Br J Pharmacol; 2010 May; 160(2):410-20. PubMed ID: 20423350
[TBL] [Abstract][Full Text] [Related]
13. Long acting inhaled beta-adrenoceptor agonists the comparative pharmacology of formoterol and salmeterol.
Anderson GP
Agents Actions Suppl; 1993; 43():253-69. PubMed ID: 8103622
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the anti-inflammatory properties of formoterol, salbutamol and salmeterol in guinea-pig skin and lung.
Whelan CJ; Johnson M; Vardey CJ
Br J Pharmacol; 1993 Oct; 110(2):613-8. PubMed ID: 7902175
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the beta 2 adrenoceptor agonist/antagonist activity of formoterol and salmeterol.
Grove A; Lipworth BJ
Thorax; 1996 Jan; 51(1):54-8. PubMed ID: 8658370
[TBL] [Abstract][Full Text] [Related]
16. Functional antagonism with formoterol and salmeterol in asthmatic patients expressing the homozygous glycine-16 beta(2)-adrenoceptor polymorphism.
Lipworth BJ; Dempsey OJ; Aziz I
Chest; 2000 Aug; 118(2):321-8. PubMed ID: 10936119
[TBL] [Abstract][Full Text] [Related]
17. Effect of short- and long-acting beta 2-adrenoceptor agonists on pulmonary beta 2-adrenoceptor expression in human lung.
Nishikawa M; Mak JC; Barnes PJ
Eur J Pharmacol; 1996 Dec; 318(1):123-9. PubMed ID: 9007523
[TBL] [Abstract][Full Text] [Related]
18. Formoterol and salmeterol are both long acting compared to terbutaline in the isolated perfused and ventilated guinea-pig lung.
Jeppsson AB; Nilsson E; Waldeck B
Eur J Pharmacol; 1994 May; 257(1-2):137-43. PubMed ID: 8082695
[TBL] [Abstract][Full Text] [Related]
19. Salmeterol, a novel, long-acting beta 2-adrenoceptor agonist: characterization of pharmacological activity in vitro and in vivo.
Ball DI; Brittain RT; Coleman RA; Denyer LH; Jack D; Johnson M; Lunts LH; Nials AT; Sheldrick KE; Skidmore IF
Br J Pharmacol; 1991 Nov; 104(3):665-71. PubMed ID: 1686740
[TBL] [Abstract][Full Text] [Related]
20. Studies on the interaction between formoterol and salmeterol in guinea-pig trachea in vitro.
Jeppsson AB; Källström BL; Waldeck B
Pharmacol Toxicol; 1992 Oct; 71(4):272-7. PubMed ID: 1360657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
